Stephanie Venn-Watson

7PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Host-parasite interactionsPredictive and prognostic markersExercise physiologyFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 16, 2025
Pentadecanoic Acid (C15:0) at Naturally Occurring Circulating Concentrations Has Selective Anticancer Activities Including Targeting B-Cell Lymphomas with CCND3 Oncogenic Alterations.

Stephanie Venn-Watson

|May 07, 2025
Aging-Associated Amyloid-β Plaques and Neuroinflammation in Bottlenose Dolphins (Tursiops truncatus) and Novel Cognitive Health-Supporting Roles of Pentadecanoic Acid (C15:0).

Stephanie Venn-Watson, Eric D Jensen

|Jul 26, 2024
The Cellular Stability Hypothesis: Evidence of Ferroptosis and Accelerated Aging-Associated Diseases as Newly Identified Nutritional Pentadecanoic Acid (C15:0) Deficiency Syndrome.

Stephanie Venn-Watson

|Nov 14, 2023
Pentadecanoic Acid (C15:0), an Essential Fatty Acid, Shares Clinically Relevant Cell-Based Activities with Leading Longevity-Enhancing Compounds.

Stephanie Venn-Watson, Nicholas J Schork

|May 26, 2022
Broader and safer clinically-relevant activities of pentadecanoic acid compared to omega-3: Evaluation of an emerging essential fatty acid across twelve primary human cell-based disease systems.

Stephanie K Venn-Watson, Camden N Butterworth

|Aug 12, 2020
A 25-y longitudinal dolphin cohort supports that long-lived individuals in same environment exhibit variation in aging rates.

Stephanie Venn-Watson, Eric D Jensen, Nicholas J Schork

Pageof 2

Frequent Collaborators

1 joint publications

Eric D Jensen

1 joint publications

Nicholas J Schork